Human Rotavirus Vaccine Market Report

Global Human Rotavirus Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 09, 2022
  • PAGES：149
  • REPORT CODE：GMM873351
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Human Rotavirus Vaccine market report explains the definition, types, applications, major countries, and major players of the Human Rotavirus Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • GlaxoSmithKline

    • Merck

    • Bharat Biotech

    By Type:

    • Rotarix

    • RotaTeq

    • Rotavac

    • Rotavin-M1

    • Lanzhou lamb

    • Others

    By End-User:

    • Hospitals & Clinics

    • Academic And Research

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Human Rotavirus Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Human Rotavirus Vaccine Outlook to 2028- Original Forecasts

    • 2.2 Human Rotavirus Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Human Rotavirus Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Human Rotavirus Vaccine Market- Recent Developments

    • 6.1 Human Rotavirus Vaccine Market News and Developments

    • 6.2 Human Rotavirus Vaccine Market Deals Landscape

    7 Human Rotavirus Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 Human Rotavirus Vaccine Key Raw Materials

    • 7.2 Human Rotavirus Vaccine Price Trend of Key Raw Materials

    • 7.3 Human Rotavirus Vaccine Key Suppliers of Raw Materials

    • 7.4 Human Rotavirus Vaccine Market Concentration Rate of Raw Materials

    • 7.5 Human Rotavirus Vaccine Cost Structure Analysis

      • 7.5.1 Human Rotavirus Vaccine Raw Materials Analysis

      • 7.5.2 Human Rotavirus Vaccine Labor Cost Analysis

      • 7.5.3 Human Rotavirus Vaccine Manufacturing Expenses Analysis

    8 Global Human Rotavirus Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Human Rotavirus Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Human Rotavirus Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Human Rotavirus Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Human Rotavirus Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Rotarix Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global RotaTeq Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Rotavac Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Rotavin-M1 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Lanzhou lamb Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Human Rotavirus Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals & Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Academic And Research Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Human Rotavirus Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global Human Rotavirus Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.2.2 Canada Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico Human Rotavirus Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.3.2 UK Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.3.3 Spain Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.3.5 France Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.3.6 Italy Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.3.8 Finland Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.3.9 Norway Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.3.11 Poland Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.3.12 Russia Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey Human Rotavirus Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.4.2 Japan Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.4.3 India Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam Human Rotavirus Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.5.3 Chile Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.5.6 Peru Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador Human Rotavirus Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.6.3 Oman Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Human Rotavirus Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria Human Rotavirus Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Human Rotavirus Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand Human Rotavirus Vaccine Consumption (2017-2022)

    11 Global Human Rotavirus Vaccine Competitive Analysis

    • 11.1 GlaxoSmithKline

      • 11.1.1 GlaxoSmithKline Company Details

      • 11.1.2 GlaxoSmithKline Human Rotavirus Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 GlaxoSmithKline Human Rotavirus Vaccine Main Business and Markets Served

      • 11.1.4 GlaxoSmithKline Human Rotavirus Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Merck

      • 11.2.1 Merck Company Details

      • 11.2.2 Merck Human Rotavirus Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Merck Human Rotavirus Vaccine Main Business and Markets Served

      • 11.2.4 Merck Human Rotavirus Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Bharat Biotech

      • 11.3.1 Bharat Biotech Company Details

      • 11.3.2 Bharat Biotech Human Rotavirus Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Bharat Biotech Human Rotavirus Vaccine Main Business and Markets Served

      • 11.3.4 Bharat Biotech Human Rotavirus Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    12 Global Human Rotavirus Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global Human Rotavirus Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Rotarix Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global RotaTeq Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Rotavac Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Rotavin-M1 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Lanzhou lamb Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Human Rotavirus Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals & Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Academic And Research Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Human Rotavirus Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global Human Rotavirus Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Human Rotavirus Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Human Rotavirus Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Human Rotavirus Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Human Rotavirus Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Human Rotavirus Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Human Rotavirus Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Human Rotavirus Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Human Rotavirus Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Human Rotavirus Vaccine

    • Figure of Human Rotavirus Vaccine Picture

    • Table Global Human Rotavirus Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Human Rotavirus Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Rotarix Consumption and Growth Rate (2017-2022)

    • Figure Global RotaTeq Consumption and Growth Rate (2017-2022)

    • Figure Global Rotavac Consumption and Growth Rate (2017-2022)

    • Figure Global Rotavin-M1 Consumption and Growth Rate (2017-2022)

    • Figure Global Lanzhou lamb Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals & Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Academic And Research Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Human Rotavirus Vaccine Consumption by Country (2017-2022)

    • Table North America Human Rotavirus Vaccine Consumption by Country (2017-2022)

    • Figure United States Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Human Rotavirus Vaccine Consumption by Country (2017-2022)

    • Figure Germany Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC Human Rotavirus Vaccine Consumption by Country (2017-2022)

    • Figure China Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America Human Rotavirus Vaccine Consumption by Country (2017-2022)

    • Figure Brazil Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC Human Rotavirus Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa Human Rotavirus Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania Human Rotavirus Vaccine Consumption by Country (2017-2022)

    • Figure Australia Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Human Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Human Rotavirus Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Human Rotavirus Vaccine Main Business and Markets Served

    • Table GlaxoSmithKline Human Rotavirus Vaccine Product Portfolio

    • Table Merck Company Details

    • Table Merck Human Rotavirus Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Human Rotavirus Vaccine Main Business and Markets Served

    • Table Merck Human Rotavirus Vaccine Product Portfolio

    • Table Bharat Biotech Company Details

    • Table Bharat Biotech Human Rotavirus Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bharat Biotech Human Rotavirus Vaccine Main Business and Markets Served

    • Table Bharat Biotech Human Rotavirus Vaccine Product Portfolio

    • Figure Global Rotarix Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global RotaTeq Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rotavac Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rotavin-M1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lanzhou lamb Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals & Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Academic And Research Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Human Rotavirus Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America Human Rotavirus Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Human Rotavirus Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Human Rotavirus Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Human Rotavirus Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Human Rotavirus Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Human Rotavirus Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Human Rotavirus Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Human Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US